QefdJNgPrENPh06SpVDKS6WIslqiFrH3wgYLGtivIjs

Best International Screenplay Call for Entries

2014 Joplin Award

Best International Screenplay

Call For Entries

 

The BlueCat Screenplay Competition remains committed to the development of screenwriters worldwide.

In this spirit, BlueCat Competition gives the Joplin Award to the Best Feature Screenplay we annually from our entrants outside the USA, Canada and the UK.

The Joplin Award winner will receive a cash prize of $1500 USD.

Every submission from entrants outside the USA, Canada and the UK is eligible for the Joplin Award, while remaining eligible for all main competition awards and receiving written analysis on each submission.

 

All Short Screenplay submissions received by June 1st will receive their feedback by June 15th

 

All Feature Screenplay submissions received by June 15th will receive their feedback by July 1st.

 

This year, BlueCat will accept short screenplays and establish one of the largest cash prizes in the world for a short screenplay contest, with the winner being awarded $10,000. Three Finalists will be receiving $1500 each.

Overall, the cash prizes will nearly double to over $43,000, with the Grand Prize for the Best Feature Screenplay increasing to $15,000. Four finalists will receive $2500 each.

The Best Feature screenplay from the UK will be awarded the Cordelia Award and will receive $1,500.

Each Short Screenplay submission will receive one written analysis, while each Feature Screenplay entry will receive two.

Students will be eligible to submit their short screenplay at a discounted rate of $29 for the duration of the competition.

Entrants will be able to submit a short screenplay with an option not to receive feedback, and all submissions will be eligible for a Resubmission entry if received by the October 15th deadline.

BlueCat prides itself in its leading reputation as a community for developing screenwriters. We hope these great changes will cement our mission—-to support and develop the undiscovered screenwriter——in all of us, today and days ahead.